ePublish

Active

Goods

Drugs and Pharmaceutical Products

Inj Aflibercept 40mg/ml

Post Graduate Institute of Medical Edu and Reserch

procurement br drugs and dressing | Chandigarh

Amount: ₹2.9 CrCloses: 15 Sept 2026

Timeline

Published6 Aug 2026
Pre-Bid Meeting17 Aug 2026
Closes15 Sept 2026
Bid Opening15 Sept 2026

Tender Value

₹2.9 Cr

EMD Value

₹5.8 L

Closing Date

15 Sept 2026, 12:30 pm

Tender Inviting Organisation

Name

PIEP

Address

room no 18A pharmacy ground floor Nehru hospital PGIMER chandigarh

Work Description

Inj Aflibercept 40mg/ml

Tender Information

Tender ID

2026_PGIME_847417_1

Reference Number

PGI/DrugsandDressing/2026/0008

Tender Type

Open Tender

Product Category

Drugs and Pharmaceutical Products

Form of Contract

Rate Contract

Period of Work

730 days

Location

procurement br drugs and dressing

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer Tender documents.

Documents Required

2 documents required · 2 mandatory

Fee/PreQual/Technical

RequiredTECHNICAL BID (.pdf)

Finance

RequiredPRICE BID (.xls)

Fee & Financial Details

Tender Fee Amount

₹0

EMD Fee Amount

₹5.8 L

Pre-Bid Meeting

Meeting Place

PGIMER chandigarh

Important Dates

Last Activity

6 Aug 2026

Published

6 Aug 2026

Bid Opening

15 Sept 2026

Download Starts

6 Aug 2026

Download Ends

15 Sept 2026

Submission Starts

6 Aug 2026

Pre-Bid Meeting

17 Aug 2026

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.03 MB

NIT Documents

Tendernotice_1.pdf

PDF • 1.30 MB

Work Item Documents

notice.pdf

Additional Documents • 0.11 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].